Literature DB >> 21504363

Defective hematopoietic stem cell and lymphoid progenitor development in the Ts65Dn mouse model of Down syndrome: potential role of oxidative stress.

Laureanne Pilar E Lorenzo1, Haiyan Chen, Kristen E Shatynski, Sarah Clark, Rong Yuan, David E Harrison, Paul J Yarowsky, Mark S Williams.   

Abstract

AIMS: Down Syndrome (DS), a genetic disease caused by a triplication of chromosome 21, is characterized by increased markers of oxidative stress. In addition to cognitive defects, patients with DS also display hematologic disorders and increased incidence of infections and leukemia. Using the Ts65Dn mouse model of DS, the goal of this study was to examine hematopoietic stem and lymphoid progenitor cell function in DS.
RESULTS: Analysis of hematopoietic progenitor populations showed that Ts65Dn mice possessed fewer functional hematopoietic stem cells and a significantly decreased percentage of bone marrow lymphoid progenitors. Increased reactive oxygen species and markers of oxidative stress were detected in hematopoietic stem cell populations and were associated with a loss of quiescence. Bone marrow progenitor populations expressed diminished levels of the IL-7Rα chain, which was associated with decreased proliferation and increased apoptosis. Modulating oxidative stress in vitro suggested that oxidative stress selectively leads to decreased IL-7Rα expression, and inhibits the survival of IL-7Rα-expressing hematopoietic progenitors, potentially linking increased reactive oxygen species and immunopathology. INNOVATION: The study results identify a link between oxidative stress and diminished IL-7Rα expression and function. Further, the data suggest that this decrease in IL-7Rα is associated with defective hematopoietic development in Down Syndrome.
CONCLUSION: The data suggest that hematopoietic stem and lymphoid progenitor cell defects underlie immune dysfunction in DS and that increased oxidative stress and reduced cytokine signaling may alter hematologic development in Ts65Dn mice.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21504363      PMCID: PMC3166202          DOI: 10.1089/ars.2010.3798

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  45 in total

1.  A clonogenic common myeloid progenitor that gives rise to all myeloid lineages.

Authors:  K Akashi; D Traver; T Miyamoto; I L Weissman
Journal:  Nature       Date:  2000-03-09       Impact factor: 49.962

Review 2.  The Ki-67 protein: from the known and the unknown.

Authors:  T Scholzen; J Gerdes
Journal:  J Cell Physiol       Date:  2000-03       Impact factor: 6.384

3.  The decline in B lymphopoiesis in aged mice reflects loss of very early B-lineage precursors.

Authors:  Juli P Miller; David Allman
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

4.  Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice.

Authors:  J T Richtsmeier; L L Baxter; R H Reeves
Journal:  Dev Dyn       Date:  2000-02       Impact factor: 3.780

5.  Early growth response 2 regulates the survival of thymocytes during positive selection.

Authors:  Victoria J Lawson; Kathleen Weston; Diane Maurice
Journal:  Eur J Immunol       Date:  2010-01       Impact factor: 5.532

6.  Hematopoietic stem cell quiescence maintained by p21cip1/waf1.

Authors:  T Cheng; N Rodrigues; H Shen; Y Yang; D Dombkowski; M Sykes; D T Scadden
Journal:  Science       Date:  2000-03-10       Impact factor: 47.728

7.  Myeloid-biased hematopoietic stem cells have extensive self-renewal capacity but generate diminished lymphoid progeny with impaired IL-7 responsiveness.

Authors:  Christa E Muller-Sieburg; Rebecca H Cho; Lars Karlsson; Jing-F Huang; Hans B Sieburg
Journal:  Blood       Date:  2004-02-19       Impact factor: 22.113

8.  Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development.

Authors:  Stephen Malin; Shane McManus; César Cobaleda; Maria Novatchkova; Alessio Delogu; Philippe Bouillet; Andreas Strasser; Meinrad Busslinger
Journal:  Nat Immunol       Date:  2009-11-29       Impact factor: 25.606

9.  Thymopoiesis independent of common lymphoid progenitors.

Authors:  David Allman; Arivazhagan Sambandam; Sungjune Kim; Juli P Miller; Antonio Pagan; David Well; Anita Meraz; Avinash Bhandoola
Journal:  Nat Immunol       Date:  2003-01-06       Impact factor: 25.606

10.  Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis.

Authors:  Gina Mundschau; Sandeep Gurbuxani; Alan S Gamis; Marianne E Greene; Robert J Arceci; John D Crispino
Journal:  Blood       Date:  2003-01-30       Impact factor: 22.113

View more
  14 in total

1.  Usp16: key controller of stem cells in Down syndrome.

Authors:  Jin-chong Xu; Valina L Dawson; Ted M Dawson
Journal:  EMBO J       Date:  2013-09-27       Impact factor: 11.598

2.  Defective thymic progenitor development and mature T-cell responses in a mouse model for Down syndrome.

Authors:  Laureanne P E Lorenzo; Kristen E Shatynski; Sarah Clark; Paul J Yarowsky; Mark S Williams
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

3.  Tumorigenesis in Down's syndrome: big lessons from a small chromosome.

Authors:  Dean Nižetić; Jürgen Groet
Journal:  Nat Rev Cancer       Date:  2012-09-21       Impact factor: 60.716

4.  Hematopoietic Stem Cells from Ts65Dn Mice Are Deficient in the Repair of DNA Double-Strand Breaks.

Authors:  Yingying Wang; Jianhui Chang; Lijian Shao; Wei Feng; Yi Luo; Marie Chow; Wei Du; Aimin Meng; Daohong Zhou
Journal:  Radiat Res       Date:  2016-05-31       Impact factor: 2.841

5.  CRLF2 overexpression results in reduced B-cell differentiation and upregulated E2F signaling in the Dp16 mouse model of Down syndrome.

Authors:  Jacob J Junco; Barry Zorman; Vincent U Gant; Jaime Muñoz; H Daniel Lacorazza; Pavel Sumazin; Karen R Rabin
Journal:  Exp Hematol       Date:  2022-03-17       Impact factor: 3.249

6.  Usp16 contributes to somatic stem-cell defects in Down's syndrome.

Authors:  Maddalena Adorno; Shaheen Sikandar; Siddhartha S Mitra; Angera Kuo; Benedetta Nicolis Di Robilant; Veronica Haro-Acosta; Youcef Ouadah; Marco Quarta; Jacqueline Rodriguez; Dalong Qian; Vadiyala M Reddy; Samuel Cheshier; Craig C Garner; Michael F Clarke
Journal:  Nature       Date:  2013-09-11       Impact factor: 49.962

7.  Muscle stem cell dysfunction impairs muscle regeneration in a mouse model of Down syndrome.

Authors:  Bradley Pawlikowski; Nicole Dalla Betta; Tiffany Elston; Darian A Williams; Bradley B Olwin
Journal:  Sci Rep       Date:  2018-03-09       Impact factor: 4.379

8.  Premature Senescence and Increased Oxidative Stress in the Thymus of Down Syndrome Patients.

Authors:  Genni Enza Marcovecchio; Francesca Ferrua; Elena Fontana; Stefano Beretta; Marco Genua; Ileana Bortolomai; Anastasia Conti; Davide Montin; Maria Teresa Cascarano; Sonia Bergante; Veronica D'Oria; Alessandro Giamberti; Donato Amodio; Caterina Cancrini; Adriano Carotti; Raffaella Di Micco; Ivan Merelli; Marita Bosticardo; Anna Villa
Journal:  Front Immunol       Date:  2021-06-01       Impact factor: 7.561

9.  Redox processes in neurodegenerative disease involving reactive oxygen species.

Authors:  Peter Kovacic; Ratnasamy Somanathan
Journal:  Curr Neuropharmacol       Date:  2012-12       Impact factor: 7.363

Review 10.  Fine-tuning the ubiquitin code at DNA double-strand breaks: deubiquitinating enzymes at work.

Authors:  Elisabetta Citterio
Journal:  Front Genet       Date:  2015-09-08       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.